Search - tctmd.com

Displaying 61 - 80 of 59286

Sort: Relevancy | Date

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Presenter: James Januzzi

March 04, 2026

Presentation THT 2026

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

Presenter: Sriram Nathan

March 04, 2026

Presentation THT 2026

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Presenter: Gregg W. Stone

March 04, 2026

Presentation THT 2026

Early Feasibility Study Of Using Venous Waveform Analysis To Estimate Right Atrial Pressures In Patients Going For Right Heart Catheterization

Presenter: Bret Alvis

March 04, 2026

Presentation THT 2026

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

Presenter: John A. Spertus

March 04, 2026

Presentation THT 2026

First Reported Real-World Outcomes of the Bodyport Cardiac Scale and Congestion Index in Heart Failure

Presenter: Marat Fudim

March 04, 2026

Presentation THT 2026

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Presenter: JoAnn Lindenfeld

March 04, 2026

Presentation THT 2026

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Presenter: Afnan Tariq

March 04, 2026

Presentation THT 2026

Interatrial Shunts: Reflections of a Seasoned Practitioner

Presenter: John R. Teerlink

March 04, 2026

Presentation THT 2026

Beyond Survival: Defining Success After Total Artificial Heart Implantation

Presenter: Andre Simon

March 04, 2026

Presentation THT 2026

Longterm Outcomes With Corvia Shunt

Presenter: Sanjiv J. Shah

March 04, 2026

Presentation THT 2026

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

Experiences With Implant-Free Interatrial Shunting

Presenter: James E. Udelson

March 04, 2026

Presentation THT 2026

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Presenter: Francis D. Pagani

March 04, 2026

Presentation THT 2026

Do We Need Shunts of Different Sizes?

Presenter: Liviu Klein

March 04, 2026

Presentation THT 2026

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Presenter: Beth A. Davison

March 04, 2026

Presentation THT 2026

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Presenter: Ryan J. Tedford

March 04, 2026

Presentation THT 2026

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Presenter: Makiko Nakamura

March 04, 2026

Presentation THT 2026

Evaluation of RV Function in Shunt Trials — Does it Matter?

Presenter: Joao L. Cavalcante

March 04, 2026

Advertisement

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Early Feasibility Study Of Using Venous Waveform Analysis To Estimate Right Atrial Pressures In Patients Going For Right Heart Catheterization

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

First Reported Real-World Outcomes of the Bodyport Cardiac Scale and Congestion Index in Heart Failure

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients

Interatrial Shunts: Reflections of a Seasoned Practitioner

Beyond Survival: Defining Success After Total Artificial Heart Implantation

Longterm Outcomes With Corvia Shunt

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

Experiences With Implant-Free Interatrial Shunting

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Do We Need Shunts of Different Sizes?

The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials

Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness

Impella-Bridge Strategy Tended To Be Associated With Lower Mortality Following Durable Left Ventricular Assist Device Implantation In Japan

Evaluation of RV Function in Shunt Trials — Does it Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content